IBDEI14E ; ; 06-AUG-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,19766,0)
 ;;=V10.43^^105^1235^44
 ;;^UTILITY(U,$J,358.3,19766,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,19766,1,4,0)
 ;;=4^V10.43
 ;;^UTILITY(U,$J,358.3,19766,1,5,0)
 ;;=5^Hx of Ovarian CA
 ;;^UTILITY(U,$J,358.3,19766,2)
 ;;=Hx of Ovarian CA^295221
 ;;^UTILITY(U,$J,358.3,19767,0)
 ;;=V12.71^^105^1235^45
 ;;^UTILITY(U,$J,358.3,19767,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,19767,1,4,0)
 ;;=4^V12.71
 ;;^UTILITY(U,$J,358.3,19767,1,5,0)
 ;;=5^Hx of Peptic Ulcer Disease
 ;;^UTILITY(U,$J,358.3,19767,2)
 ;;=^303400
 ;;^UTILITY(U,$J,358.3,19768,0)
 ;;=V10.46^^105^1235^48
 ;;^UTILITY(U,$J,358.3,19768,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,19768,1,4,0)
 ;;=4^V10.46
 ;;^UTILITY(U,$J,358.3,19768,1,5,0)
 ;;=5^Hx of Prostate Cancer
 ;;^UTILITY(U,$J,358.3,19768,2)
 ;;=Hx of Prostate Cancer^295224
 ;;^UTILITY(U,$J,358.3,19769,0)
 ;;=V11.0^^105^1235^50
 ;;^UTILITY(U,$J,358.3,19769,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,19769,1,4,0)
 ;;=4^V11.0
 ;;^UTILITY(U,$J,358.3,19769,1,5,0)
 ;;=5^Hx of Schizophrenia
 ;;^UTILITY(U,$J,358.3,19769,2)
 ;;=Hx of Schizophrenia^295249
 ;;^UTILITY(U,$J,358.3,19770,0)
 ;;=V10.83^^105^1235^51
 ;;^UTILITY(U,$J,358.3,19770,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,19770,1,4,0)
 ;;=4^V10.83
 ;;^UTILITY(U,$J,358.3,19770,1,5,0)
 ;;=5^Hx of Skin Cancer (Non-Melanoma)
 ;;^UTILITY(U,$J,358.3,19770,2)
 ;;=^295241
 ;;^UTILITY(U,$J,358.3,19771,0)
 ;;=V15.1^^105^1235^53
 ;;^UTILITY(U,$J,358.3,19771,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,19771,1,4,0)
 ;;=4^V15.1
 ;;^UTILITY(U,$J,358.3,19771,1,5,0)
 ;;=5^Hx of Surgery To Heart And Great Vessels
 ;;^UTILITY(U,$J,358.3,19771,2)
 ;;=^295283
 ;;^UTILITY(U,$J,358.3,19772,0)
 ;;=V15.82^^105^1235^57
 ;;^UTILITY(U,$J,358.3,19772,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,19772,1,4,0)
 ;;=4^V15.82
 ;;^UTILITY(U,$J,358.3,19772,1,5,0)
 ;;=5^Hx of Tobacco Use (not current)
 ;;^UTILITY(U,$J,358.3,19772,2)
 ;;=Hx of Tobacco Use (not current)^303405
 ;;^UTILITY(U,$J,358.3,19773,0)
 ;;=V12.01^^105^1235^54
 ;;^UTILITY(U,$J,358.3,19773,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,19773,1,4,0)
 ;;=4^V12.01
 ;;^UTILITY(U,$J,358.3,19773,1,5,0)
 ;;=5^Hx of TB
 ;;^UTILITY(U,$J,358.3,19773,2)
 ;;=Hx of TB^303393
 ;;^UTILITY(U,$J,358.3,19774,0)
 ;;=V13.01^^105^1235^36
 ;;^UTILITY(U,$J,358.3,19774,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,19774,1,4,0)
 ;;=4^V13.01
 ;;^UTILITY(U,$J,358.3,19774,1,5,0)
 ;;=5^Hx of Kidney Stones
 ;;^UTILITY(U,$J,358.3,19774,2)
 ;;=Hx of Kidney Stones^303403
 ;;^UTILITY(U,$J,358.3,19775,0)
 ;;=V12.51^^105^1235^59
 ;;^UTILITY(U,$J,358.3,19775,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,19775,1,4,0)
 ;;=4^V12.51
 ;;^UTILITY(U,$J,358.3,19775,1,5,0)
 ;;=5^Hx of Venous Thrombosis And Embolism
 ;;^UTILITY(U,$J,358.3,19775,2)
 ;;=^303397
 ;;^UTILITY(U,$J,358.3,19776,0)
 ;;=V17.89^^105^1235^18
 ;;^UTILITY(U,$J,358.3,19776,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,19776,1,4,0)
 ;;=4^V17.89
 ;;^UTILITY(U,$J,358.3,19776,1,5,0)
 ;;=5^Family h/o Musculosk Disease
 ;;^UTILITY(U,$J,358.3,19776,2)
 ;;=^332861
 ;;^UTILITY(U,$J,358.3,19777,0)
 ;;=V12.54^^105^1235^56
 ;;^UTILITY(U,$J,358.3,19777,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,19777,1,4,0)
 ;;=4^V12.54
 ;;^UTILITY(U,$J,358.3,19777,1,5,0)
 ;;=5^Hx of TIA
 ;;^UTILITY(U,$J,358.3,19777,2)
 ;;=^335309
 ;;^UTILITY(U,$J,358.3,19778,0)
 ;;=V12.54^^105^1235^52
 ;;^UTILITY(U,$J,358.3,19778,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,19778,1,4,0)
 ;;=4^V12.54
 ;;^UTILITY(U,$J,358.3,19778,1,5,0)
 ;;=5^Hx of Stroke w/o Residual
 ;;^UTILITY(U,$J,358.3,19778,2)
 ;;=^335309
 ;;
 ;;$END ROU IBDEI14E
